India · Delayed Price · Currency is INR Orchard Therapeutics Statistics
Total Valuation
BOM:530197 has a market cap or net worth of INR 976.27 million. The enterprise value is 1.09 billion.
| Market Cap | 976.27M |
| Enterprise Value | 1.09B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:530197 has 5.92 million shares outstanding. The number of shares has decreased by -21.21% in one year.
| Current Share Class | 5.92M |
| Shares Outstanding | 5.92M |
| Shares Change (YoY) | -21.21% |
| Shares Change (QoQ) | -8.43% |
| Owned by Insiders (%) | 56.65% |
| Owned by Institutions (%) | 2.22% |
| Float | 1.48M |
Valuation Ratios
The trailing PE ratio is 36.68.
| PE Ratio | 36.68 |
| Forward PE | n/a |
| PS Ratio | 2.90 |
| PB Ratio | 3.84 |
| P/TBV Ratio | 7.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.26, with an EV/FCF ratio of -10.46.
| EV / Earnings | 68.95 |
| EV / Sales | 3.24 |
| EV / EBITDA | 36.26 |
| EV / EBIT | 36.57 |
| EV / FCF | -10.46 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.33 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 2.47 |
| Debt / FCF | -0.71 |
| Interest Coverage | 24.73 |
Financial Efficiency
Return on equity (ROE) is 13.79% and return on invested capital (ROIC) is 8.10%.
| Return on Equity (ROE) | 13.79% |
| Return on Assets (ROA) | 5.50% |
| Return on Invested Capital (ROIC) | 8.10% |
| Return on Capital Employed (ROCE) | 11.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.99 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:530197 has paid 1.75 million in taxes.
| Income Tax | 1.75M |
| Effective Tax Rate | 6.17% |
Stock Price Statistics
The stock price has increased by +11.05% in the last 52 weeks. The beta is -0.18, so BOM:530197's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | +11.05% |
| 50-Day Moving Average | 166.61 |
| 200-Day Moving Average | 150.23 |
| Relative Strength Index (RSI) | 45.81 |
| Average Volume (20 Days) | 605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:530197 had revenue of INR 336.98 million and earned 15.83 million in profits. Earnings per share was 4.50.
| Revenue | 336.98M |
| Gross Profit | 94.82M |
| Operating Income | 29.85M |
| Pretax Income | 28.40M |
| Net Income | 15.83M |
| EBITDA | 30.10M |
| EBIT | 29.85M |
| Earnings Per Share (EPS) | 4.50 |
Balance Sheet
The company has 26.14 million in cash and 74.42 million in debt, giving a net cash position of -48.28 million or -8.16 per share.
| Cash & Cash Equivalents | 26.14M |
| Total Debt | 74.42M |
| Net Cash | -48.28M |
| Net Cash Per Share | -8.16 |
| Equity (Book Value) | 254.16M |
| Book Value Per Share | 57.92 |
| Working Capital | 94.74M |
Cash Flow
In the last 12 months, operating cash flow was -101.46 million and capital expenditures -2.92 million, giving a free cash flow of -104.38 million.
| Operating Cash Flow | -101.46M |
| Capital Expenditures | -2.92M |
| Free Cash Flow | -104.38M |
| FCF Per Share | -17.65 |
Margins
Gross margin is 28.14%, with operating and profit margins of 8.86% and 4.70%.
| Gross Margin | 28.14% |
| Operating Margin | 8.86% |
| Pretax Margin | 8.43% |
| Profit Margin | 4.70% |
| EBITDA Margin | 8.93% |
| EBIT Margin | 8.86% |
| FCF Margin | n/a |
Dividends & Yields
BOM:530197 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 21.21% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.62% |
| FCF Yield | -10.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |